SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001358403-15-000048
Filing Date
2015-07-15
Accepted
2015-07-15 16:58:24
Documents
1
Period of Report
2015-07-13

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_143699389500163.html 3  
1 FORM 3 wf-form3_143699389500163.xml 3 1694
  Complete submission text file 0001358403-15-000048.txt   3179
Mailing Address NEUROGEN CORP 35 NORTHEAST INDUSTRIAL RD BRANFORD CT 06405
Business Address
DAVIS STEPHEN (Reporting) CIK: 0001131146 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36783 | Film No.: 15989748

Mailing Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030
Business Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Issuer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations